Autotransplants in Chronic Myeloid Leukemia

  • Carella A
3Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

INTRODUCTION: Chronic myeloid leukemia (CML) is a clonal myeloproliferative disease due to a unique gene rearrangement event occurring within a pluripotent stem cell. The main characteristic of this mutation is the formation of a fusion gene (BCR-ABL) with increased tyrosine kinase activity from which a transforming activity for myelopoiesis derives. Clinically, CML is characterized by an initial chronic phase, followed by inevitable progression to an accelerated phase, and then to a terminal blastic phase. Allografting represents the only therapeutic procedure capable of curing the disease. Most centers currently use HLA-identical sibling transplants for patients less than 55 years of age. However, the majority of patients do not have an HLA-matched sibling donor. Matched or partially matched unrelated donor transplants are associated with a high transplant-related mortality within the first 100 days following the procedure. This approach should be offered to patients less than 50 years of age. Conventional therapy for CML includes hydroxyurea, busulfan and interferon alpha (IFN-&agr;). Conventional chemotherapy is unable to modify the natural history of the disease. On the contrary, recent randomized studies suggest that IFN-&agr; produces cytogenetic conversions to Philadelphia (Ph)-negative in some cases and may prolong overall survival [1-5]. Considering that the majority of Ph-negative patients maintain evidence of BCR/ABL positivity after IFN-&agr; therapy, it is unlikely that IFN-&agr; can cure the disease. In upcoming years, we must evaluate whether the high cost of IFN-&agr;, the poor tolerance of it in about one-fourth of treated patients, and the small chance of long-term benefit will be justified by a higher overall survival than with hydroxyurea. About 70% of CML patients do not have a matched family donor, and unrelated transplantation may produce high morbidity, particularly in older patients. For these patients and for those who do not achieve a cytogenetic remission after IFN-&agr; therapy, alternative treatment strategies are needed to increase disease-free survival. Autologous stem cell transplantation (ASCT) has been explored as an option for the treatment of these patients. In this review, we will focus on the recent update of this procedure, particularly on the in vivo manipulation technique.

References Powered by Scopus

Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia

0
663Citations
N/AReaders
Get full text

Randomized comparison of interferon-α with busulfan and hydroxyurea in chronic myelogenous leukemia

463Citations
N/AReaders
Get full text

UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response

425Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The post-transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phase

11Citations
N/AReaders
Get full text

Chronic myelogenous leukemia: Elements of conventional chemotherapy and an overview of autografting in the treatment of the chronic phase

1Citations
N/AReaders
Get full text

Personalized medical treatment strategies for patients with chronic myeloid leukemia

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Carella, A. M. (1998). Autotransplants in Chronic Myeloid Leukemia. The Oncologist, 3(1), 54–60. https://doi.org/10.1634/theoncologist.3-1-54

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

60%

Professor / Associate Prof. 1

20%

Researcher 1

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 1

25%

Biochemistry, Genetics and Molecular Bi... 1

25%

Nursing and Health Professions 1

25%

Economics, Econometrics and Finance 1

25%

Save time finding and organizing research with Mendeley

Sign up for free